Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.

Kong SY, Tran HQ, Gewirtz AT, McKeown-Eyssen G, Fedirko V, Romieu I, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Bastide N, Affret A, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Kritikou M, Vasilopoulou E, Palli D, Krogh V, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Sala N, Sánchez MJ, Castaño JM, Barricarte A, Dorronsoro M, Werner M, Wareham NJ, Khaw KT, Bradbury KE, Freisling H, Stavropoulou F, Ferrari P, Gunter MJ, Cross AJ, Riboli E, Bruce WR, Jenab M.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):291-301. doi: 10.1158/1055-9965.EPI-15-0798. Epub 2016 Jan 11.

2.

Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings.

Yang K, Fard S, Furrer R, Archer MC, Bruce WR, Lip H, Mehta R, O'Brien PJ, Giacca A, Ward WE, Femia AP, Caderni G, Medline A, Banks K.

Nutr Cancer. 2016;68(1):94-104. doi: 10.1080/01635581.2016.1115098. Epub 2015 Dec 28.

3.

The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.

Kong SY, Takeuchi M, Hyogo H, McKeown-Eyssen G, Yamagishi S, Chayama K, O'Brien PJ, Ferrari P, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Bastide N, Carbonnel F, Kühn T, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Vasilopoulou E, Masala G, Pala V, Santucci De Magistris M, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Jakszyn P, Sánchez MJ, Dorronsoro M, Gavrila D, Ardanaz E, Rutegård M, Nyström H, Wareham NJ, Khaw KT, Bradbury KE, Romieu I, Freisling H, Stavropoulou F, Gunter MJ, Cross AJ, Riboli E, Jenab M, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1855-63. doi: 10.1158/1055-9965.EPI-15-0422. Epub 2015 Sep 24.

4.

Biomarkers of exposure to endogenous oxidative and aldehyde stress.

Bruce WR, Lee O, Liu Z, Marcon N, Minkin S, O'Brien PJ.

Biomarkers. 2011 Aug;16(5):453-6. doi: 10.3109/1354750X.2011.580369.

PMID:
21777170
5.

Cytotoxic molecular mechanisms and cytoprotection by enzymic metabolism or autoxidation for glyceraldehyde, hydroxypyruvate and glycolaldehyde.

Yang K, Feng C, Lip H, Bruce WR, O'Brien PJ.

Chem Biol Interact. 2011 May 30;191(1-3):315-21. doi: 10.1016/j.cbi.2011.02.027. Epub 2011 Mar 3.

PMID:
21376711
6.

Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity.

Yang K, Qiang D, Delaney S, Mehta R, Bruce WR, O'Brien PJ.

Chem Biol Interact. 2011 May 30;191(1-3):322-9. doi: 10.1016/j.cbi.2011.02.012. Epub 2011 Feb 18.

PMID:
21334317
7.

Hepatocyte inflammation model for cytotoxicity research: fructose or glycolaldehyde as a source of endogenous toxins.

Feng CY, Wong S, Dong Q, Bruce J, Mehta R, Bruce WR, O'Brien PJ.

Arch Physiol Biochem. 2009 May;115(2):105-11. doi: 10.1080/13813450902887055.

PMID:
19485706
8.

Fructose and carbonyl metabolites as endogenous toxins.

Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, O'Brien PJ.

Chem Biol Interact. 2009 Mar 16;178(1-3):332-9. doi: 10.1016/j.cbi.2008.10.011. Epub 2008 Oct 18.

PMID:
19000661
9.

Dehydroalanine and lysinoalanine in thermolyzed casein do not promote colon cancer in the rat.

Corpet DE, Taché S, Archer MC, Bruce WR.

Food Chem Toxicol. 2008 Sep;46(9):3037-42. doi: 10.1016/j.fct.2008.06.002. Epub 2008 Jun 10.

10.

A thermolyzed diet increases oxidative stress, plasma alpha-aldehydes and colonic inflammation in the rat.

Shangari N, Depeint F, Furrer R, Bruce WR, Popovic M, Zheng F, O'Brien PJ.

Chem Biol Interact. 2007 Aug 30;169(2):100-9. Epub 2007 Jun 8.

PMID:
17659267
11.

Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways.

Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ.

Chem Biol Interact. 2006 Oct 27;163(1-2):113-32. Epub 2006 May 24. Review.

PMID:
16814759
12.

Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.

Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ.

Chem Biol Interact. 2006 Oct 27;163(1-2):94-112. Epub 2006 May 1. Review.

PMID:
16765926
13.

Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo.

Tran TT, Naigamwalla D, Oprescu AI, Lam L, McKeown-Eyssen G, Bruce WR, Giacca A.

Endocrinology. 2006 Apr;147(4):1830-7. Epub 2006 Jan 12.

PMID:
16410309
14.
15.
16.

Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats.

Karlsson PC, Hughes R, Rafter JJ, Bruce WR.

Cancer Lett. 2005 Jun 8;223(2):203-9. Epub 2004 Nov 19.

PMID:
15896454
17.

Marginal dietary thiamin deficiency induces the formation of colonic aberrant crypt foci (ACF) in rats.

Bruce WR, Furrer R, Shangari N, O'Brien PJ, Medline A, Wang Y.

Cancer Lett. 2003 Dec 30;202(2):125-9.

PMID:
14643441
18.

Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency.

Shangari N, Bruce WR, Poon R, O'Brien PJ.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1390-3. Review.

PMID:
14641070
20.

Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats.

Tran TT, Gupta N, Goh T, Naigamwalla D, Chia MC, Koohestani N, Mehrotra S, McKeown-Eyssen G, Giacca A, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):47-56.

21.

Possible mechanisms relating diet to colorectal cancer risk.

Bruce WR, Giacca A, Medline A.

IARC Sci Publ. 2002;156:277-81. Review. No abstract available.

PMID:
12484187
22.

Power-frequency electromagnetic fields and exposure geometry.

Bruce WR, Stewart AT, Stuchly MA.

Radiat Res. 2001 Jul;156(1):123. No abstract available.

PMID:
11418081
23.

Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse.

Naigamwalla D, Chia MC, Tran TT, Medline A, Hay K, Gallinger S, Bruce WR.

Cancer Res. 2000 Dec 15;60(24):6856-8.

24.

Possible mechanisms relating diet and risk of colon cancer.

Bruce WR, Giacca A, Medline A.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1271-9. Review.

25.

Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.

Bruce WR, Wolever TM, Giacca A.

Nutr Cancer. 2000;37(1):19-26. Review.

PMID:
10965515
26.

Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy.

Koohestani N, Chia MC, Pham NA, Tran TT, Minkin S, Wolever TM, Bruce WR.

Carcinogenesis. 1998 Sep;19(9):1679-84.

PMID:
9771941
27.

Thermally oxidized dietary fat and colon carcinogenesis in rodents.

Yang CM, Kendall CW, Stamp D, Medline A, Archer MC, Bruce WR.

Nutr Cancer. 1998;30(1):69-73.

PMID:
9507516
28.

Rapid quantitation of thermal oxidation products in fats and oils by 1H-NMR spectroscopy.

Yang CM, Grey AA, Archer MC, Bruce WR.

Nutr Cancer. 1998;30(1):64-8.

PMID:
9507515
29.

Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet.

Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR.

Nutr Cancer. 1997;29(1):69-76.

PMID:
9383787
30.

The colonic protein fermentation and insulin resistance hypotheses for colon cancer etiology: experimental tests using precursor lesions.

Bruce WR, Corpet DE.

Eur J Cancer Prev. 1996 Dec;5 Suppl 2:41-7. No abstract available.

PMID:
9061294
31.

Insulin promotion of colon tumors in rats.

Tran TT, Medline A, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):1013-5.

32.

Natural history of aberrant crypt foci. A surgical approach.

Shpitz B, Hay K, Medline A, Bruce WR, Bull SB, Gallinger S, Stern H.

Dis Colon Rectum. 1996 Jul;39(7):763-7.

PMID:
8674368
33.

Dietary cholesterol inhibits the development of aberrant crypt foci in the colon.

el-Sohemy A, Kendall CW, Rao AV, Archer MC, Bruce WR.

Nutr Cancer. 1996;25(2):111-7.

PMID:
8710680
34.

Inhibition of rat mammary tumorigenesis by dietary cholesterol.

el-Sohemy A, Bruce WR, Archer MC.

Carcinogenesis. 1996 Jan;17(1):159-62.

PMID:
8565127
35.

Colonic protein fermentation and promotion of colon carcinogenesis by thermolyzed casein.

Corpet DE, Yin Y, Zhang XM, Rémésy C, Stamp D, Medline A, Thompson L, Bruce WR, Archer MC.

Nutr Cancer. 1995;23(3):271-81.

36.

A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group.

McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V, Cohen LB, Pappas SC, Saibil FG.

J Clin Epidemiol. 1994 May;47(5):525-36. Erratum in: J Clin Epidemiol 1995 Feb;48(2):i.

PMID:
7730878
37.

Diet, aberrant crypt foci and colorectal cancer.

Bruce WR, Archer MC, Corpet DE, Medline A, Minkin S, Stamp D, Yin Y, Zhang XM.

Mutat Res. 1993 Nov;290(1):111-8. Review.

PMID:
7694090
38.

K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.

Vivona AA, Shpitz B, Medline A, Bruce WR, Hay K, Ward MA, Stern HS, Gallinger S.

Carcinogenesis. 1993 Sep;14(9):1777-81.

PMID:
8403199
39.

Sucrose enhancement of the early steps of colon carcinogenesis in mice.

Stamp D, Zhang XM, Medline A, Bruce WR, Archer MC.

Carcinogenesis. 1993 Apr;14(4):777-9.

PMID:
8472347
40.

Initiation and promotion of colonic aberrant crypt foci in rats by 5-hydroxymethyl-2-furaldehyde in thermolyzed sucrose.

Zhang XM, Chan CC, Stamp D, Minkin S, Archer MC, Bruce WR.

Carcinogenesis. 1993 Apr;14(4):773-5.

PMID:
8472346
41.

Aberrant crypt foci and microadenoma as markers for colon cancer.

Archer MC, Bruce WR, Chan CC, Corpet DE, Medline A, Roncucci L, Stamp D, Zhang XM.

Environ Health Perspect. 1992 Nov;98:195-7.

42.

Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein.

Zhang XM, Stamp D, Minkin S, Medline A, Corpet DE, Bruce WR, Archer MC.

J Natl Cancer Inst. 1992 Jul 1;84(13):1026-30.

PMID:
1608054
43.

Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins.

Kashtan H, Stern HS, Jenkins DJ, Jenkins AL, Hay K, Marcon N, Minkin S, Bruce WR.

Am J Clin Nutr. 1992 May;55(5):976-80.

PMID:
1315121
44.

Colonic fermentation and markers of colorectal-cancer risk.

Kashtan H, Stern HS, Jenkins DJ, Jenkins AL, Thompson LU, Hay K, Marcon N, Minkin S, Bruce WR.

Am J Clin Nutr. 1992 Mar;55(3):723-8.

PMID:
1312764
45.

The effect of lowering faecal pH on the rate of proliferation of the normal colonic mucosa.

Gregoire RC, Kashtan H, Stern HS, Yeung KS, Stadler J, Neil GA, Furrer R, Langley S, Bruce WR.

Surg Oncol. 1992 Feb;1(1):43-7.

PMID:
1341234
46.

Classification of aberrant crypt foci and microadenomas in human colon.

Roncucci L, Medline A, Bruce WR.

Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):57-60.

47.

Identification and quantification of aberrant crypt foci and microadenomas in the human colon.

Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR.

Hum Pathol. 1991 Mar;22(3):287-94.

PMID:
1706308
48.

Effect of high-fat and low-fiber meals on the cell proliferation activity of colorectal mucosa.

Gregoire R, Yeung KS, Stadler J, Stern HS, Kashtan H, Neil G, Bruce WR.

Nutr Cancer. 1991;15(1):21-6.

PMID:
1850128
49.

Manipulation of fecal pH by dietary means.

Kashtan H, Stern HS, Jenkins DJ, Gregoire R, Hay K, Jenkins AL, Minkin S, Bruce WR.

Prev Med. 1990 Nov;19(6):607-13.

PMID:
2263571
50.

Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat.

Corpet DE, Stamp D, Medline A, Minkin S, Archer MC, Bruce WR.

Cancer Res. 1990 Nov 1;50(21):6955-8.

Supplemental Content

Loading ...
Support Center